share_log

Piper Sandler Reiterates Overweight on Omega Therapeutics, Lowers Price Target to $9

Benzinga ·  Apr 3 11:27

Piper Sandler analyst Edward Tenthoff reiterates Omega Therapeutics (NASDAQ:OMGA) with a Overweight and lowers the price target from $10 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment